Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of APD403 for prevention of chemotherapy-induced nausea and vomiting
2013-001635-51Phase 2Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of amisulpride in chemotherapy-induced nausea and vomiting (CINV) (4 arms), sponsored by Acacia Pharma Group Plc. Primary endpoint: Complete response in delayed phase. Started Jun 2013; status: completed.
02
Drugs
amisulpride
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2013-001635-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001635-51.